The formulation comparison between a biosimilar and a branded biologic. The cost, availability, and supply chain benefits of ...

There’s currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...

Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

In addition, publicly available 2024 sales data of biosimilar antibodies and proteins as well as of new biologic modalities such as gene and cell therapy and RNA (antisense, siRNA) are included in ...

Just as a map shows you how to reach a destination in the real world, Ampersand Biomedicines’ map of tissues of the human body shows where a drug should go in the biological one. Now the startup ...

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended ...

Robert Sidbury MD, MPH explored the “long list” of treatment options in atopic dermatitis and how the treatment landscape has changed as a result in a video interview with Healio.“So long list – I ...

The use of biologics is rapidly increasing as new drugs are approved for label expansions. Monoclonal antibodies, multispecific antibodies, and antibody-drug conjugates (ADCs) are being ...